v3.25.4
SCHEDULE OF BASIC AND DILUTED COMMON SHARE (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net Change in Net Assets Resulting from Operations per Common Share:                              
Net change in net assets resulting from operations                         $ 48,808,336 $ (38,124,247) $ 5,066,822
Weighted-average common shares–basic 25,212,863 24,371,533 23,728,095 23,571,840 23,436,365 23,378,002 23,410,235 25,393,490 25,251,921 25,351,306 25,952,447 28,378,529 24,225,991 23,901,805 26,222,667
Earnings per common share–basic $ (0.80) $ 0.30 $ 2.63 $ (0.03) $ (0.23) $ (0.45) $ (0.87) $ (0.36) $ 0.99 $ (0.60) $ 0.16 $ 2.01 $ (1.60) $ 0.19
Net change in net assets resulting from operations                         $ 48,808,336 $ (38,124,247) $ 5,066,822
Adjustment for interest and amortization on 6.50% Convertible Notes due 2029 [1]                         2,499,717
Net change in net assets resulting from operations, as adjusted                         51,308,053 (38,124,247) 5,066,822
Adjustment for dilutive effect of 6.50% Convertible Notes due 2029 [1]                         $ 4,563,109
Weighted-average common shares outstanding–diluted [1]                         28,789,100 23,901,805 26,222,627
Earnings per common share–diluted                         $ 1.78 $ (1.60) $ 0.19
[1] For the year ended December 31, 2024, 3,870,969 potentially dilutive common shares were excluded from the weighted-average common shares outstanding for diluted net decrease in net assets resulting from operations per common shares because the effect of these shares would have been anti-dilutive. For the year ended December 31, 2023, there were no potentially dilutive securities outstanding.